Sae (a pseudonym) and her husband were initially in disbelief when doctors diagnosed her with cancer. Over the years, MRI scans of Sae's mother showed progressive improvement, especially following 2019, which influenced Sae’s and her husband’s outlook.
Sae（化名）和她的丈夫最初难以相信医生的癌症诊断。然而，随着时间的推移，Sae母亲的MRI扫描显示出了显著的改善，特别是在2019年后，这也影响了Sae和她丈夫的看法。In May 2014, 9.5 years ago, Sae’s MRI results revealed clustered foreign tissue in her breast with surrounding small spreads. A biopsy confirmed a malignant diagnosis. Her physician in Tokyo suggested the conventional treatment: a radical mastectomy followed by chemotherapy and radiation. However, the doctor warned that her specific cancer type was chemo- and radio-resistant, with a high likelihood of recurrence and metastasis, even with surgery. Her tumour type was a hard structure, rapid growth, and ease of metastasis. Within six months, the tumor had doubled in size.
2014年5月，距今已有9.5年，Sae的MRI结果显示她的乳房内有成簇的异常组织，并伴有小范围的扩散。活检证实了恶性肿瘤的诊断。她的东京医生建议采取传统治疗方案，即进行根治性乳房切除术，然后进行化疗和放疗。然而，医生警告说，她的癌症类型对化疗和放疗具有耐药性，即使手术治疗，复发和转移的可能性仍然很高。她的肿瘤类型具有硬结构、快速生长和易于转移的特性。在六个月内，肿瘤的大小增加了一倍。Seeking alternatives, Sae and her husband consulted another physician in Osaka. In early October, they found a doctor specializing in immune therapy who proposed a treatment plan that excluded surgery and chemotherapy. This approach involved ECCT in combination with immune therapy.
为了寻找替代方案，Sae和她的丈夫咨询了大阪的另一位医生。10月初，他们找到了专门从事免疫治疗的医生，该医生提出了一种不需要手术和化疗的治疗方案，即结合ECCT和免疫治疗的治疗方法。Intrigued by the potential of ECCT, Sae and her husband committed to it, recognizing it as their best chance to treat breast cancer without surgery and chemotherapy. Between 2014 and 2019, her cancer remained relatively stable, showing neither significant improvement nor worsening, and importantly, no metastasis. However, substantial progress began in late 2019. By the following year, MRIs indicated a near 50% reduction in the cancer mass, and subsequent MRIs showed a steady reduction to the point of near-clearance.
Remarkably, throughout her decade-long journey with cancer, Sae has maintained her general health and vitality, with no outward signs of serious illness. She has not required painkillers or anti-inflammatory medications, which are commonly used among cancer patients. During the COVID-19 pandemic, Sae remained unaffected despite her husband testing positive for the virus while they shared a household.
Sae和她的丈夫对ECCT的潜力产生了兴趣，并选择了这种方法，认为这是他们最好的机会。在2014年至2019年期间，她的癌症状况相对稳定，没有显著改善也没有恶化，最重要的是没有发生转移。然而，在2019年底出现了显著的进展。到次年，MRI显示癌症肿块减少了近50％，随后的MRI显示癌症肿块持续减少，几乎达到清除的程度。令人惊讶的是，在她长达十年的癌症治疗过程中，Sae保持了良好的整体健康状态，没有明显的重病迹象。她从未像大多数癌症患者那样需要服用止痛药或抗炎药。在新冠疫情期间，尽管她的丈夫确诊了新冠，Sae却未受到感染，两人还住在同一屋檐下。By the end of 2024, nearly ten years after her initial diagnosis, MRI results showed a significantly diminished tumor mass, with only minimal residual spots detectable.
到2024年底，距离最初诊断将近十年，Sae的MRI结果显示肿瘤肿块明显减少，仅有少量残留斑点可检测到。
Comments